AbstractPurpose:. Docetaxel improves survival in metastatic hormone-sensitive prostate cancer (mHSPC) and high-risk localized disease, but benefits vary substantially among patients. Without predictiv...

AbstractPurpose:. Docetaxel improves survival in metastatic hormone-sensitive prostate cancer (mHSPC) and high-risk localized disease, but benefits vary substantially among patients. Without predictiv...

AbstractPurpose:. Docetaxel improves survival in metastatic hormone-sensitive prostate cancer (mHSPC) and high-risk localized disease, but benefits vary substantially among patients. Without predictiv...

Classification methods based on deep learning require selecting between fully-supervised or weakly-supervised approaches, each presenting limitations in uncertainty quantification and interpretability...